• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 215/12 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Patent holdings for IPC class C07D 215/12

Total number of patents in this class: 463

10-year publication summary

25
26
26
41
24
32
21
19
24
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Merck Patent GmbH
5847
13
Bristol-myers Squibb Company
4883
11
Janssen Pharmaceutica N.V.
3624
8
Sun Pharma Advanced Research Company Ltd.
200
7
The Regents of the University of California
19493
6
Ohio State Innovation Foundation
1968
6
Hendrix College
16
6
VALO Health, Inc.
167
6
The Scripps Research Institute
1352
5
Agc, Inc.
4434
5
Shaanxi Lighte Optoelectronics Material Co., Ltd.
222
5
Novartis AG
11289
4
Samsung Display Co., Ltd.
32700
4
Boehringer Ingelheim International GmbH
4756
4
Massachusetts Institute of Technology
9909
4
Toray Industries, Inc.
6843
4
Katholieke Universiteit Leuven
1099
4
Vib VZW
845
4
The Board of Regents of the University of Texas System
2130
4
The Royal Institution for The Advancement of Learning / McGill University
664
4
Other owners 349